Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANJIVANI PA vs DECIPHER LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANJIVANI PA DECIPHER LABS SANJIVANI PA/
DECIPHER LABS
 
P/E (TTM) x 29.7 -2.1 - View Chart
P/BV x - 0.6 - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 SANJIVANI PA   DECIPHER LABS
EQUITY SHARE DATA
    SANJIVANI PA
Mar-23
DECIPHER LABS
Mar-23
SANJIVANI PA/
DECIPHER LABS
5-Yr Chart
Click to enlarge
High Rs6863 107.9%   
Low Rs2514 176.5%   
Sales per share (Unadj.) Rs35.545.1 78.7%  
Earnings per share (Unadj.) Rs4.5-2.7 -169.9%  
Cash flow per share (Unadj.) Rs5.4-2.2 -241.8%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs-3.123.0 -13.4%  
Shares outstanding (eoy) m10.0010.10 99.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.30.9 153.1%   
Avg P/E ratio x10.3-14.5 -70.9%  
P/CF ratio (eoy) x8.6-17.3 -49.8%  
Price / Book Value ratio x-15.11.7 -901.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m464389 119.2%   
No. of employees `000NANA-   
Total wages/salary Rs m29412 7.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m355456 77.9%  
Other income Rs m974 12.8%   
Total revenues Rs m364529 68.8%   
Gross profit Rs m53-106 -49.4%  
Depreciation Rs m94 207.5%   
Interest Rs m45 74.5%   
Profit before tax Rs m49-42 -118.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4-15 -29.3%   
Profit after tax Rs m45-27 -168.2%  
Gross profit margin %14.8-23.3 -63.5%  
Effective tax rate %8.835.5 24.7%   
Net profit margin %12.7-5.9 -216.0%  
BALANCE SHEET DATA
Current assets Rs m83201 41.2%   
Current liabilities Rs m22750 457.1%   
Net working cap to sales %-40.533.2 -122.1%  
Current ratio x0.44.1 9.0%  
Inventory Days Days5330 176.5%  
Debtors Days Days20,452,423789 2,591,395.8%  
Net fixed assets Rs m12771 180.1%   
Share capital Rs m100101 99.0%   
"Free" reserves Rs m-131131 -99.7%   
Net worth Rs m-31232 -13.2%   
Long term debt Rs m80-   
Total assets Rs m210272 77.4%  
Interest coverage x14.8-7.6 -193.6%   
Debt to equity ratio x-0.20-  
Sales to assets ratio x1.71.7 100.7%   
Return on assets %23.2-8.1 -286.1%  
Return on equity %-146.9-11.6 1,271.1%  
Return on capital %-229.4-15.8 1,447.5%  
Exports to sales %63.80-   
Imports to sales %3.50-   
Exports (fob) Rs m227NA-   
Imports (cif) Rs m13NA-   
Fx inflow Rs m2270-   
Fx outflow Rs m130-   
Net fx Rs m2140-   
CASH FLOW
From Operations Rs m47-16 -299.3%  
From Investments Rs m-10-43 23.2%  
From Financial Activity Rs m-37-22 173.5%  
Net Cashflow Rs m0-80 0.5%  

Share Holding

Indian Promoters % 32.3 0.0 -  
Foreign collaborators % 0.0 16.4 -  
Indian inst/Mut Fund % 6.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 67.7 83.6 81.0%  
Shareholders   4,500 34,511 13.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANJIVANI PA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SANJIVANI PA vs COMBAT DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SANJIVANI PA vs COMBAT DRUGS Share Price Performance

Period SANJIVANI PA COMBAT DRUGS S&P BSE HEALTHCARE
1-Day -1.54% 0.68% 1.18%
1-Month -14.43% -17.62% -0.75%
1-Year 382.32% -1.07% 61.82%
3-Year CAGR 138.94% -24.12% 18.16%
5-Year CAGR 100.77% -10.83% 19.79%

* Compound Annual Growth Rate

Here are more details on the SANJIVANI PA share price and the COMBAT DRUGS share price.

Moving on to shareholding structures...

The promoters of SANJIVANI PA hold a 32.3% stake in the company. In case of COMBAT DRUGS the stake stands at 16.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SANJIVANI PA and the shareholding pattern of COMBAT DRUGS.

Finally, a word on dividends...

In the most recent financial year, SANJIVANI PA paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

COMBAT DRUGS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of SANJIVANI PA, and the dividend history of COMBAT DRUGS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.